Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 222

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 222
---
 shares underlying the APx Warrants under applicable state securities laws, and in the event APx does not so elect, APx will use its best efforts to register or qualify the shares underlying the APx Warrants under applicable state securities laws to the extent an exemption is not available. 90 In no event will APx be required to net cash settle any APx Warrant, or issue securities (other than upon a cashless exercise as described above) or other compensation in exchange for the APx Warrants in the event that APx is unable to register or qualify the shares underlying the APx Warrants under the Securities Act or applicable state securities laws. You may only be able to exercise your Public Warrants on a “cashless basis” under certain circumstances, and if you do so, you will receive fewer shares from such exercise than if you were to exercise such Public Warrants for cash. The SPAC Warrant Agreement provides that in the following circumstances holders of APx Warrants who seek to exercise their APx Warrants will not be permitted to do for cash and will, instead, be required to do so on a cashless basis in accordance with Section 3(a)(9) of the Securities Act: (i) if the ordinary shares issuable upon exercise of the APx Warrants are not registered under the Securities Act in accordance with the terms of the SPAC Warrant Agreement; (ii) if APx has so elected and the ordinary shares are at the time of any exercise of an APx Warrant not listed on a national securities exchange such that they satisfy the definition of “covered securities” under Section 18(b)(1) of the Securities Act; and (iii) if APx has so elected and APx will call the Public Warrants for redemption. If you exercise your Public Warrants on a cashless basis, you would pay the APx Warrant exercise price by surrendering the APx Warrants for that number of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of the ordinary shares underlying the APx Warrants, multiplied by the excess of the “fair market value” of the ordinary shares (as defined in the next sentence) over the exercise price of the APx Warrants by (y) the fair market value. The “fair market value” is the average reported closing price of the ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of exercise is received by the warrant agent